|
⚲
|
| Keyboard |
| Sager Philip
✚
|
|
|---|---|
| CIK # | 0001610170 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001610170] | |
| 4 | [0001610170] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Anthera Pharmaceuticals Inc | |
| Sager Philip |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2018-01-05 | Grant | 84,705 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2018-01-05 | Grant | 84,705 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2016-04-27 | Grant | 41,379 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2015-05-21 | Grant | 28,846 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2014-12-30 | Grant | 15,000 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2014-06-13 | Grant | 18,750 | $0.00 | |
|
Anthera Pharmaceuticals Inc ANTH
Stock Option (right to buy) · derivative
|
2014-06-13 | Grant | 12,500 | $0.00 |